---
description: 維生素C相關學術文獻彙整 2026-02，整理最新研究成果與證據等級分析。
generated_at: '2026-02-19T02:04:15.637356+00:00'
grand_parent: 維生素C
json_ld:
  '@context': https://schema.org
  '@graph':
  - '@id': https://supplement.weiqi.kids/reports/vitamin-c/literature/2026-02#webpage
    '@type': WebPage
    dateModified: '2026-02-19'
    datePublished: '2026-02-19'
    description: 維生素C相關學術文獻彙整 2026-02，整理最新研究成果與證據等級分析。
    inLanguage: zh-TW
    isPartOf:
      '@id': https://supplement.weiqi.kids#website
    name: 維生素C文獻薈萃 2026-02
    speakable:
      '@type': SpeakableSpecification
      cssSelector:
      - .article-summary
      - .speakable-content
      - .key-takeaway
      - .key-answer
      - .expert-quote
      - .actionable-steps li
      - .faq-answer-content
    url: https://supplement.weiqi.kids/reports/vitamin-c/literature/2026-02
  - '@id': https://supplement.weiqi.kids#organization
    '@type': Organization
    alternateName: Supplement Intelligence
    contactPoint:
      '@type': ContactPoint
      contactType: customer service
      email: info@weiqi.kids
    logo:
      '@type': ImageObject
      height: 60
      url: https://supplement.weiqi.kids/assets/images/logo.png
      width: 600
    name: 保健食品情報系統
    sameAs:
    - https://github.com/weiqi-kids/agent.supplement-product
    url: https://supplement.weiqi.kids
  - '@id': https://supplement.weiqi.kids#website
    '@type': WebSite
    name: 保健食品情報系統
    potentialAction:
      '@type': SearchAction
      query-input: required name=search_term
      target: https://supplement.weiqi.kids/search?q={search_term}
    url: https://supplement.weiqi.kids
  - '@id': https://supplement.weiqi.kids/reports/vitamin-c/literature/2026-02#article
    '@type': Article
    articleSection: 文獻薈萃
    author:
      '@id': https://supplement.weiqi.kids/about#person
      '@type': Person
      hasCredential:
      - '@type': EducationalOccupationalCredential
        credentialCategory: AI System
        description: 整合六大市場官方資料庫的 AI 分析系統
        name: AI 資料分析系統
      knowsAbout:
      - 保健食品市場分析
      - 膳食補充劑法規
      - 成分趨勢研究
      - 全球市場情報
      - 產品資料萃取
      name: 保健食品情報 AI
      url: https://supplement.weiqi.kids/about
    dateModified: '2026-02-19'
    datePublished: '2026-02-19'
    description: 維生素C相關學術文獻彙整 2026-02，整理最新研究成果與證據等級分析。
    headline: 維生素C文獻薈萃 2026-02
    inLanguage: zh-TW
    isAccessibleForFree: true
    isPartOf:
      '@id': https://supplement.weiqi.kids#website
    keywords: 維生素C,文獻回顧,學術研究,證據分析
    mainEntityOfPage:
      '@id': https://supplement.weiqi.kids/reports/vitamin-c/literature/2026-02#webpage
    publisher:
      '@id': https://supplement.weiqi.kids#organization
    wordCount: 491
  - '@type': BreadcrumbList
    itemListElement:
    - '@type': ListItem
      item: https://supplement.weiqi.kids
      name: 首頁
      position: 1
    - '@type': ListItem
      item: https://supplement.weiqi.kids/reports/vitamin-c
      name: 維生素C
      position: 2
    - '@type': ListItem
      item: https://supplement.weiqi.kids/reports/vitamin-c/literature
      name: 文獻薈萃
      position: 3
    - '@type': ListItem
      item: https://supplement.weiqi.kids/reports/vitamin-c/literature/2026-02
      name: 2026-02
      position: 4
  - '@id': https://supplement.weiqi.kids/reports/vitamin-c/literature/2026-02#primaryimage
    '@type': ImageObject
    creditText: 保健食品情報系統
    height: 630
    license: https://creativecommons.org/licenses/by-nc/4.0/
    representativeOfPage: true
    url: https://supplement.weiqi.kids/assets/images/og-default.png
    width: 1200
layout: default
nav_order: 202602
parent: 文獻薈萃
title: 維生素C文獻薈萃 2026-02
topic: vitamin-c
total_articles: 479
---

# 維生素C文獻薈萃報告 — 2026 年 2 月

## 摘要

本月共收錄 維生素C 相關文獻 479 篇，其中 Level 1 證據（Meta-Analysis/Systematic Review）11 篇，RCT 2 篇。

## 證據等級分布

| 證據等級 | 文獻數 | 佔比 |
|----------|--------|------|
| Level 1 (Meta-Analysis/Systematic Review) | 11 | 2.3% |
| Level 2 (RCT) | 2 | 0.4% |
| Level 3 (Clinical Trial) | 2 | 0.4% |
| Level 4 (Observational) | 2 | 0.4% |
| Level 5 (Review/Case Report/Other) | 462 | 96.5% |

## 功效分類統計

| 功效分類 | 中文 | 文獻數 | 佔比 |
|----------|------|--------|------|
| other | 其他 | 268 | 55.9% |
| immune | 免疫調節 | 60 | 12.5% |
| cardiovascular | 心血管 | 44 | 9.2% |
| anti_aging | 抗衰老 | 42 | 8.8% |
| cognitive | 認知功能 | 38 | 7.9% |
| metabolic | 代謝 | 35 | 7.3% |
| energy | 活力 | 31 | 6.5% |
| musculoskeletal | 肌肉骨骼 | 28 | 5.8% |
| digestive | 消化 | 16 | 3.3% |
| skin | 皮膚 | 13 | 2.7% |
| sexual | 性功能 | 12 | 2.5% |

## 成分搭配統計

| 成分 | 文獻數 |
|------|--------|
| EPA | 58 |
| iron | 46 |
| NAC | 18 |
| calcium | 11 |
| fiber | 7 |
| vitamin C | 4 |
| collagen | 4 |
| zinc | 3 |
| stem cell | 3 |
| whey protein | 3 |

## 成分組合分析

以下列出最常被共同研究的成分組合：

| 成分組合 | 共同出現文獻數 |
|----------|---------------|
| EPA + iron | 8 |
| iron + whey protein | 3 |
| NAC + calcium | 2 |
| EPA + NAC | 2 |
| EPA + stem cell | 2 |
| EPA + fiber | 2 |
| fiber + vitamin C | 2 |
| calcium + fiber | 2 |

## 成分功效分析

以下列出主要成分在各功效領域的研究文獻數：

| 成分 | 總文獻 | 其他 | 免疫調節 | 肌肉骨骼 | 心血管 | 抗衰老 | 代謝 |
|------|--------|--------|--------|--------|--------|--------|--------|
| EPA | 58 | 29 | 14 | 8 | 5 | 6 | 8 |
| iron | 46 | 29 | 7 | 3 | 3 | 4 | 3 |
| NAC | 18 | 10 | 2 | 3 | 1 | 2 | - |
| calcium | 11 | 3 | 1 | 4 | 4 | - | 1 |
| fiber | 7 | 3 | - | 3 | - | - | - |

## 研究類型分布

| 研究類型 | 文獻數 | 佔比 |
|----------|--------|------|
| Meta-Analysis | 7 | 1.5% |
| Systematic Review | 4 | 0.8% |
| RCT | 2 | 0.4% |
| Clinical Trial | 2 | 0.4% |
| Observational | 2 | 0.4% |
| Review | 19 | 4.0% |
| Case Report | 12 | 2.5% |
| Other | 431 | 90.0% |

## 近期重要文獻

### Level 1 證據（Meta-Analysis / Systematic Review）

1. **[The Effect of Cranberry Consumption on C-Reactive Protein and Interleukin-6: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.](https://pubmed.ncbi.nlm.nih.gov/41704730/)** — Food science & nutrition, 2026-02-01
   - 功效分類：immune

2. **[Pre-procedural C-reactive protein levels and carotid or intracranial artery restenosis: A systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41704432/)** — Atherosclerosis plus, 2026-03-01
   - 功效分類：immune

3. **[Evaluating the safety, pharmacokinetics, and antiparasitic activity of DSM265, a novel antimalarial plasmodium dihydroorotate dehydrogenase inhibitor: a systematic review and meta-analysis of early clinical trials.](https://pubmed.ncbi.nlm.nih.gov/41703549/)** — Malaria journal, 2026-02-17
   - 功效分類：other

4. **[Prevalence and Correlates of Adverse Childhood Experiences in LGBTQ+ Populations: A Narrative Review and Meta-Analysis.](https://pubmed.ncbi.nlm.nih.gov/41703448/)** — Trauma, violence & abuse, 2026-02-17
   - 功效分類：sexual

5. **[Comparative efficacy of immune checkpoint inhibitor-based regimens versus tyrosine kinase inhibitors in advanced hepatocellular carcinoma stratified by etiology: a systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41701457/)** — International journal of clinical oncology, 2026-02-17
   - 功效分類：immune


### Level 2 證據（RCT）

1. **[Effectiveness and safety of cyclosporine A in moderate to severe COVID-19: a randomized, open-label trial.](https://pubmed.ncbi.nlm.nih.gov/41702946/)** — Scientific reports, 2026-02-17
   - 功效分類：immune

2. **[A Randomized Phase 1 Study Comparing the PK, PD, Safety, and Immunogenicity of Proposed Biosimilar RGB-14-X and Denosumab in Healthy Adult Males.](https://pubmed.ncbi.nlm.nih.gov/41703781/)** — Clinical and translational science, 2026-02-01
   - 功效分類：musculoskeletal



---

<div class="disclaimer" markdown="1">

**免責聲明**

本網站內容由 AI 自動生成，基於各國官方公開資料庫的產品登記資訊。
報告內容僅供參考，不構成醫療建議、投資建議或商業建議。
如有健康問題，請諮詢專業醫療人員。

產品統計以資料庫登記為準，不代表實際市場銷售狀況。
各國監管制度不同，跨國比較應考慮法規差異。

</div>
